advertisement
Ji D 34
Showing records 1 to 25 | Display all abstracts from Ji D122975 Protective Effect of Nicotinamide Riboside on Glucocorticoid-Induced Glaucoma: Mitigating Mitochondrial Damage and Extracellular Matrix Deposition
Zhang N
Investigative Ophthalmology and Visual Science 2024; 65: 1
122314 The role of nicotinamide riboside in the preservation of retinal ganglion cells using an in vitro glutamate-induced excitotoxicity model
Zhang N
Experimental Eye Research 2024; 248: 110126
120382 Self-Assembly Hypoxic and ROS Dual Response Nano Prodrug as a New Therapeutic Approach for Glaucoma Treatments
Zhou X
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2024; 11: e2407043
121583 Development of Nitric Oxide-Donating Netarsudil Derivatives as a Synergistic Therapy for Glaucoma with Reduced Ocular Irritation
Li C; Zhu M
Journal of Medicinal Chemistry 2024; 67: 16311-16327
120382 Self-Assembly Hypoxic and ROS Dual Response Nano Prodrug as a New Therapeutic Approach for Glaucoma Treatments
Rong R
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2024; 11: e2407043
122314 The role of nicotinamide riboside in the preservation of retinal ganglion cells using an in vitro glutamate-induced excitotoxicity model
Ji D
Experimental Eye Research 2024; 248: 110126
122975 Protective Effect of Nicotinamide Riboside on Glucocorticoid-Induced Glaucoma: Mitigating Mitochondrial Damage and Extracellular Matrix Deposition
Zhang P; Deng X
Investigative Ophthalmology and Visual Science 2024; 65: 1
121583 Development of Nitric Oxide-Donating Netarsudil Derivatives as a Synergistic Therapy for Glaucoma with Reduced Ocular Irritation
Liu S
Journal of Medicinal Chemistry 2024; 67: 16311-16327
120382 Self-Assembly Hypoxic and ROS Dual Response Nano Prodrug as a New Therapeutic Approach for Glaucoma Treatments
Liang G
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2024; 11: e2407043
122314 The role of nicotinamide riboside in the preservation of retinal ganglion cells using an in vitro glutamate-induced excitotoxicity model
Hu Y
Experimental Eye Research 2024; 248: 110126
122975 Protective Effect of Nicotinamide Riboside on Glucocorticoid-Induced Glaucoma: Mitigating Mitochondrial Damage and Extracellular Matrix Deposition
Zhu M
Investigative Ophthalmology and Visual Science 2024; 65: 1
121583 Development of Nitric Oxide-Donating Netarsudil Derivatives as a Synergistic Therapy for Glaucoma with Reduced Ocular Irritation
Zhang J
Journal of Medicinal Chemistry 2024; 67: 16311-16327
120382 Self-Assembly Hypoxic and ROS Dual Response Nano Prodrug as a New Therapeutic Approach for Glaucoma Treatments
Wu Y
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2024; 11: e2407043
122314 The role of nicotinamide riboside in the preservation of retinal ganglion cells using an in vitro glutamate-induced excitotoxicity model
Zhang P
Experimental Eye Research 2024; 248: 110126
121583 Development of Nitric Oxide-Donating Netarsudil Derivatives as a Synergistic Therapy for Glaucoma with Reduced Ocular Irritation
Ye H
Journal of Medicinal Chemistry 2024; 67: 16311-16327
122314 The role of nicotinamide riboside in the preservation of retinal ganglion cells using an in vitro glutamate-induced excitotoxicity model
Deng X
Experimental Eye Research 2024; 248: 110126
120382 Self-Assembly Hypoxic and ROS Dual Response Nano Prodrug as a New Therapeutic Approach for Glaucoma Treatments
Xu C
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2024; 11: e2407043
122975 Protective Effect of Nicotinamide Riboside on Glucocorticoid-Induced Glaucoma: Mitigating Mitochondrial Damage and Extracellular Matrix Deposition
Hu Y
Investigative Ophthalmology and Visual Science 2024; 65: 1
120382 Self-Assembly Hypoxic and ROS Dual Response Nano Prodrug as a New Therapeutic Approach for Glaucoma Treatments
Xiao H
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2024; 11: e2407043
122314 The role of nicotinamide riboside in the preservation of retinal ganglion cells using an in vitro glutamate-induced excitotoxicity model
Zhu M
Experimental Eye Research 2024; 248: 110126
122975 Protective Effect of Nicotinamide Riboside on Glucocorticoid-Induced Glaucoma: Mitigating Mitochondrial Damage and Extracellular Matrix Deposition
Ji D
Investigative Ophthalmology and Visual Science 2024; 65: 1
121583 Development of Nitric Oxide-Donating Netarsudil Derivatives as a Synergistic Therapy for Glaucoma with Reduced Ocular Irritation
Zhang C
Journal of Medicinal Chemistry 2024; 67: 16311-16327
122314 The role of nicotinamide riboside in the preservation of retinal ganglion cells using an in vitro glutamate-induced excitotoxicity model
Zeng W
Experimental Eye Research 2024; 248: 110126
120382 Self-Assembly Hypoxic and ROS Dual Response Nano Prodrug as a New Therapeutic Approach for Glaucoma Treatments
Ji D
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2024; 11: e2407043
121583 Development of Nitric Oxide-Donating Netarsudil Derivatives as a Synergistic Therapy for Glaucoma with Reduced Ocular Irritation
Ji D
Journal of Medicinal Chemistry 2024; 67: 16311-16327
